A
Austrianova
A cutting edge Biotech company based in Singapore embracing leading world quality standards for the production
About Austrianova
Austrianova specializes in cell encapsulation technology, providing innovative solutions for the protection, storage, and transport of living cells and biological molecules. Operating in the biotechnology sector, Austrianova serves pharmaceutical companies, research institutions, and biotech firms. The company's core product is its proprietary cell encapsulation technology, which allows for the free diffusion of nutrients and waste products while protecting cells from external threats. This technology is used for various applications, including immunoprotection, localization in patients, and ambient storage of probiotic bacteria and yeast. Austrianova's business model is B2B, offering a full GMP service for living eukaryotic human and animal cells, including cell banking and processing in compliance with US FDA standards. The company generates revenue through service contracts and partnerships with other biotech firms.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2001
- Headquarters
- Singapore, Singapore
- Employees
- 10
- Open positions
- None listed
- Dealroom signal
- 70.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Mar 2023 | $0 | — | Checkmate Capital Group | ↗ |
| LATE VC✓Equity / VC | Jul 2021 | $1.1M | $193M | UntroD Capital | — |
Growth signals
Latest recorded traffic for Austrianova is 230 monthly website visits, up 43.8% over the last three months. Austrianova's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Ryan Group Holdings
UntroD Capital- CGCheckmate Capital Group
Other known investors1 additional known investor
University of Veterinary Medicine Vienna
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Austrianova on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Austrianova’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.